You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 26, 2025

Drug Price Trends for NDC 65162-0705


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 65162-0705

Drug NameNDCPrice/Unit ($)UnitDate
ESCITALOPRAM OXALATE 5 MG/5 ML 65162-0705-88 0.16684 ML 2025-04-23
ESCITALOPRAM OXALATE 5 MG/5 ML 65162-0705-88 0.18071 ML 2025-03-19
ESCITALOPRAM OXALATE 5 MG/5 ML 65162-0705-88 0.16898 ML 2025-02-19
ESCITALOPRAM OXALATE 5 MG/5 ML 65162-0705-88 0.17161 ML 2025-01-22
ESCITALOPRAM OXALATE 5 MG/5 ML 65162-0705-88 0.16360 ML 2024-12-18
ESCITALOPRAM OXALATE 5 MG/5 ML 65162-0705-88 0.16325 ML 2024-11-20
ESCITALOPRAM OXALATE 5 MG/5 ML 65162-0705-88 0.17675 ML 2024-10-23
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 7 of 7 entries

Best Wholesale Price for NDC 65162-0705

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
ESCITALOPRAM OXALATE 5MG/5ML LIQUID,ORAL AvKare, LLC 65162-0705-88 240ML 102.36 0.42650 2024-05-15 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 1 of 1 entries

Market Analysis and Price Projections for NDC: 65162-0705 (Escitalopram Oxalate)

Introduction

Escitalopram Oxalate, with the National Drug Code (NDC) 65162-0705, is a prescription medication manufactured by Amneal Pharmaceuticals LLC. It is primarily used to treat major depressive disorder and generalized anxiety disorder. Here, we will delve into the market analysis and price projections for this drug.

Market Overview

The pharmaceutical market, particularly for generic drugs like Escitalopram Oxalate, is highly competitive and subject to various regulatory and economic factors.

Competitive Landscape

Escitalopram Oxalate is a generic version of the brand-name drug Lexapro. The generic market for this drug is crowded, with multiple manufacturers competing for market share. This competition often leads to price stability or even reductions, as companies strive to remain competitive[2].

Regulatory Environment

Regulatory changes and policies can significantly impact drug pricing. For instance, the evolving regulatory landscape, including measures to control drug price inflation, can influence how manufacturers set their prices. In recent years, there has been a focus on reducing prescription drug prices, which could affect the pricing strategy for Escitalopram Oxalate[3].

Historical Price Trends

To understand the potential future price trends, it is crucial to examine the historical price changes.

Recent Price Increases

From January 2022 to January 2023, the pharmaceutical industry saw significant price increases, with over 4,200 drug products experiencing price hikes. The average price increase was 15.2%, which translates to $590 per drug product. However, multi-source drugs like Escitalopram Oxalate tend to have higher percentage increases but lower absolute dollar increases compared to single-source drugs[2].

Specific to Escitalopram Oxalate

While specific historical price data for NDC 65162-0705 is not provided in the sources, it is reasonable to assume that it follows the general trend of generic drugs. Generic drugs often see smaller price increases compared to brand-name drugs, but they can still be affected by broader market trends.

Factors Influencing Price Projections

Cost of Production

Increases in the cost of active pharmaceutical ingredients (APIs), materials, and other supplies can lead to price increases. However, these costs are often offset by other factors such as economies of scale and competitive pressures[4].

Regulatory and Policy Changes

Policy changes aimed at controlling drug prices can directly impact the pricing of Escitalopram Oxalate. For example, measures to cap price increases or impose inflation rebates can limit the extent to which manufacturers can raise prices[2].

Market Demand and Competition

The demand for antidepressants and anxiolytics remains steady, driven by the prevalence of mental health disorders. However, the competitive nature of the generic drug market keeps prices relatively stable. Manufacturers must balance the need to maintain profitability with the need to remain competitive.

Price Projections

Short-Term Projections

Given the recent trends, it is likely that the price of Escitalopram Oxalate will experience modest increases in the short term. These increases will likely be in line with or slightly above the rate of inflation, reflecting the broader market trends.

Long-Term Projections

In the long term, the price of Escitalopram Oxalate is expected to remain relatively stable or see minimal increases. The competitive generic market and regulatory pressures to control drug prices will likely keep significant price hikes in check.

Key Statistics and Trends

  • Average Price Increase: From January 2022 to January 2023, the average price increase for prescription drugs was 15.2%, but for multi-source drugs like Escitalopram Oxalate, the average increase was 26.0% in percentage terms, though with lower absolute dollar values[2].
  • Regulatory Impact: Regulatory measures such as inflation rebates and price caps can reduce the average price increase. For example, CMS uses quarterly and 12-month measures for Part B and Part D inflation rebates, respectively[2].
  • Market Size: The biopharma and biotech markets, which include generic drugs, are growing rapidly, with the biopharma market projected to have a CAGR of 7.56% between 2024 and 2029[3].

Expert Insights

"The pharmaceutical industry is undergoing significant changes, driven by technological advancements, evolving regulatory frameworks, and a shift towards patient-centered care. These changes will continue to shape the pricing and development of drugs like Escitalopram Oxalate."[3]

Conclusion

The price of Escitalopram Oxalate (NDC 65162-0705) is influenced by a complex interplay of market competition, regulatory policies, and production costs. While short-term price increases may align with broader market trends, long-term stability is expected due to the competitive nature of the generic drug market.

Key Takeaways

  • Market Competition: The generic market for Escitalopram Oxalate is highly competitive, which tends to stabilize prices.
  • Regulatory Environment: Regulatory changes aimed at controlling drug prices will influence future price trends.
  • Historical Trends: Recent price increases in the pharmaceutical industry have been significant, but multi-source drugs see smaller absolute dollar increases.
  • Long-Term Stability: The price of Escitalopram Oxalate is expected to remain relatively stable in the long term.

FAQs

1. What is the primary use of Escitalopram Oxalate? Escitalopram Oxalate is primarily used to treat major depressive disorder and generalized anxiety disorder.

2. Who manufactures Escitalopram Oxalate with NDC 65162-0705? Amneal Pharmaceuticals LLC manufactures Escitalopram Oxalate with the NDC 65162-0705.

3. How do regulatory changes impact drug prices? Regulatory changes, such as measures to control price inflation and impose inflation rebates, can directly impact the pricing of drugs like Escitalopram Oxalate.

4. What are the expected short-term price trends for Escitalopram Oxalate? Short-term price trends are likely to see modest increases, in line with or slightly above the rate of inflation.

5. How does the competitive market affect the price of generic drugs like Escitalopram Oxalate? The competitive nature of the generic drug market tends to keep prices relatively stable, as manufacturers must balance profitability with competitiveness.

Sources

  1. FindACode: Amneal Pharmaceuticals LLC - List of Drugs - NDC Labeler.
  2. ASPE: Changes in the List Prices of Prescription Drugs, 2017-2023.
  3. TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025.
  4. DFS NY: Drug Price Increases Report - November 2024.
  5. DailyMed: TEMOZOLOMIDE capsule.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.